Activation of Cyclin D1-Cdk4 and Cdk4-Directed Phosphorylation of RB Protein in Diabetic Mesangial Hypertrophy

  1. Denis Féliers12,
  2. Meredith A. Frank2 and
  3. Daniel J. Riley12
  1. 1Department of Medicine, Division of Nephrology, South Texas Veterans Health Care System, San Antonio, Texas
  2. 2University of Texas Health Science Center at San Antonio, San Antonio, Texas

    Abstract

    To determine the role of cell-cycle proteins in regulating pathological renal hypertrophy, diabetes was induced in mice expressing a human retinoblastoma (RB) transgene and in wild-type littermates. Whole-kidney and glomerular hypertrophy caused by hyperglycemia was associated with specific G1 phase cell-cycle events: early and sustained increase in expression of cyclin D1 and activation of cyclin D1-cdk4 complexes, but no change in expression of cyclin E or cdk2 activity. Overexpression of RB alone likewise caused hypertrophy and increased only cyclin D1-cdk4 activity; these effects were not further augmented by high glucose. Identical observations were made when isolated mesangial cells conditionally overexpressing RB from a tetracycline-repressible system hypertrophied in response to high glucose. A mitogenic signal in the same cell-culture system, in contrast, transiently and sequentially activated both cyclin D1-cdk4 and cyclin E-cdk2. In vivo and in cultured mesangial cells, high glucose resulted in persistent partial phosphorylation of RB, an event catalyzed specifically by cyclin D1-cdk4. These data indicate that mesangial hypertrophy caused by hyperglycemia in diabetes results in sustained cyclin D1-cdk4-dependent phosphorylation of RB and maintenance of mesangial cells in the early-to-middle G1 phase of the cell cycle.

    Footnotes

    • Address correspondence and reprint requests to Daniel J. Riley, Medicine/Nephrology, MC 7882, UTHSCSA, 7703 Floyd Curl Dr., San Antonio, TX 78229. E-mail: rileyd{at}uthscsa.edu.

      Received for publication 18 April 2002 and accepted in revised form 5 August 2002.

      CKI, cyclin kinase inhibitor; DMEM, Dulbecco’s modified Eagle’s medium; FACS, fluorescence-activated cell sorter; FBS, fetal bovine serum; FLS, forward light scatter; HDAC, histone deacetylase; MMC, mouse mesangial cell; MMCtetRB, mouse mesangial cells with tetracycline-controllable expression of human RB transgene; MMCwt, mouse mesangial cells from wild-type littermates; PAS, periodic acid-Schiff; RB, retinoblastoma; STZ, streptozotocin; tet, tetracycline; TGF-β, transforming growth factor-β.

    « Previous | Next Article »Table of Contents